PartnerFacts
Data last updated: Oct 23, 2026, 5:45 PM ETLatest filing: Oct 22, 2026Now: Oct 24, 2026, 5:27 AM ET

Sponsor Check › Person

OO
No photo found yet (own website and image search run after this page is viewed)

Oded Orgil

Named as an officer, director or promoter on SEC Form D filings · Israel (as filed: L3), Alberta, Canada (as filed: A0) · Oct 2, 2023 → Aug 21, 2026

1deal (issuers)
$1.63Mreported sold
6investors
11Form D filings
2023–2026years on file

Data last updated Oct 23, 2026, 5:45 PM ET · Courts (RECAP) last checked: Oct 24, 2026, 2:55 AM ET · SEC enforcement last checked: covered by the index scan as of Oct 24, 2026, 2:50 AM ET

The short version

Oded Orgil is listed as a director on 11 SEC Form D filings by 1 issuer between Oct 2023 and Aug 2026: NurExone Biologic Inc. (Technion City, Haifa, Israel (as filed: L3) — biotechnology — 2023–2026; $1.63M reported sold to 6 investors).

What this means One deal on file with the SEC. A Form D is the notice a company files after it starts selling a private investment — it is a notice, not an approval.

Listed alongside Eran Ovadya (11 shared filings), Lior Shaltiel (11 shared filings), Yoram Drucker (11 shared filings), James Richardson (10 shared filings), Gadi Riesenfeld (4 shared filings) and 2 others.

What this means These are the other officers, directors or promoters the companies named on the same forms — the team around Oded. Each name links to their own page.

Public records searched: federal courts (CourtListener / RECAP), SEC enforcement releases, state securities regulators (AZ, CA, DE, TX, WA) — 3 court cases matching the name listed in Key records below.

What this means 3 records came back. Each one is listed below with a link to the original document and a line saying why it matched. A name match is not proof it is the same person or company — read the why line and the document. Being sued or named in a release is an accusation, not a finding.

We compared 11 public filings for Oded Orgil and found 7 differences: Form D filed 38 days after the first sale; No amendment in the last 12 months on an offering that may still be open; and more below.

What this means These are differences between the sponsor's own SEC filings — both values, dates and sources are listed in Key records, section 4. Most have ordinary explanations; ask the sponsor.

What the community is saying

Community search for Oded Orgil has not run yet — it is joining a line of 16,456 names; searches run around the clock at the hosts' allowed rate. Searched so far: 28 names.

Community comments are quoted as written by their authors. Sources searched: BiggerPockets forums (via DuckDuckGo, Brave, Bing and BiggerPockets search) and Reddit (search feed + public archive).

Key records

Five things investors ask first. Items still in human review are counted, not shown.

1. Lawsuits

3 cases: 3 dismissed

Orgil International Greenhouses, Corp. v. Villasenor dismissed
District Court, S.D. California · No. 3:12-cv-01863 · Filed Jul 27, 2012 · Closed Apr 4, 2013 · Nature of suit: 190 Other contract actions
Role of Orgil International Greenhouses, Corp.: Plaintiff · Outcome: Terminated 2013-04-04 — FJC Integrated Database disposition: Voluntarily dismissed Docket on CourtListener ↗
same rare surname (1 person in Form D filings, 3 federal dockets); surname only in the caption; court in CA (not a filing state)
Arriaga v. Orgil International Greenhouses Corp. dismissed
District Court, S.D. California · No. 3:07-cv-00217 · Filed Feb 1, 2007 · Closed Feb 10, 2009 · Nature of suit: Contract: Other · Cause: 28:1332oc Diversity-Other Contract
Role of Orgil International Greenhouses Corp.: Defendant · Outcome: Terminated 2009-02-10 — FJC Integrated Database disposition: Dismissed: settled Docket on CourtListener ↗
same rare surname (1 person in Form D filings, 3 federal dockets); surname only in the caption; court in CA (not a filing state)
Navobampo SPR De RL v. Orgil International dismissed
District Court, S.D. California · No. 3:00-cv-02592 · Filed Dec 29, 2000 · Closed Aug 30, 2002 · Nature of suit: 380 Other personal property damage
Role of Orgil International: Defendant · Outcome: Terminated 2002-08-30 — FJC Integrated Database disposition: Dismissed: settled Docket on CourtListener ↗
same rare surname (1 person in Form D filings, 3 federal dockets); surname only in the caption; court in CA (not a filing state)
What was searched

Sources searched: CourtListener bulk data (RECAP dockets as of 2026-09-30; recall-first rule 10-24) — federal district + bankruptcy courts State courts: not covered (one-tap state court links under Look further). PACER: not searched. · Last checked Oct 24, 2026, 2:55 AM ET.

Court records show docket facts only; we never restate allegations as facts. Outcome wording comes from the docket feed; where it does not state a disposition we say so.

State courts: not covered (one-tap state court links under Look further). No state offers a lawful automated statewide source PartnerFacts can use today. Texas (re:SearchTX) terms prohibit storing results in a database open to third parties; New York (WebCivil) and Massachusetts (MassCourts) require a browser check that blocks scripted queries; California has no statewide index (58 county portals; Rule of Court 2.503 grants name-based access case by case); Florida, Utah and Illinois offer paid or partial access whose terms for automated use are unverified. Washington (dw.courts.wa.gov; bulk index reports under a JISC data-dissemination agreement), Delaware (CourtConnect; Court of Chancery not included) and Arizona (apps.azcourts.gov/publicaccess, which has an official channel to request high-volume access) are the candidates; PartnerFacts will request written permission before any automated search. Federal courts are searched through CourtListener / RECAP.

2. Regulatory actions

None found in sources searched — SEC enforcement releases (index scan as of Oct 24, 2026, 2:50 AM ET) · state securities regulators: AZ, CA, DE, TX, WA (crawled Oct 23, 2026)

What was searched

SEC enforcement searched: SEC litigation releases and administrative proceedings — respondent names in the sec.gov index titles (30,205 releases, 1995-09-19 to 2026-10-23); release text is read only to confirm a candidate. Names that appear only in the body of a release are not found. — Searched SEC litigation releases and administrative proceedings (1995→ / 2007→) (30,205 records as of Oct 24, 2026, 2:50 AM ET) — nothing matched Oded Orgil..

State securities regulators searched: AZ (Corporation Commission Securities Division), CA (DFPI — 16 of 12,159 DFPI respondent pages read so far; sponsor-name matches are read first), DE (DOJ Investor Protection Unit), TX (State Securities Board), WA (DFI) — last crawled Oct 23, 2026, 9:57 PM ET. Other states are not covered.

3. Bankruptcies

None found in sources searched — federal bankruptcy courts (CourtListener / RECAP), checked Oct 24, 2026

What was searched

Sources searched: Federal bankruptcy courts via CourtListener / RECAP archive (federal district courts, federal bankruptcy courts). State courts: not covered (one-tap state court links under Look further). PACER: not searched (RECAP only). · Last checked Oct 24, 2026, 2:55 AM ET.

State courts: not covered (one-tap state court links under Look further). No state offers a lawful automated statewide source PartnerFacts can use today. Texas (re:SearchTX) terms prohibit storing results in a database open to third parties; New York (WebCivil) and Massachusetts (MassCourts) require a browser check that blocks scripted queries; California has no statewide index (58 county portals; Rule of Court 2.503 grants name-based access case by case); Florida, Utah and Illinois offer paid or partial access whose terms for automated use are unverified. Washington (dw.courts.wa.gov; bulk index reports under a JISC data-dissemination agreement), Delaware (CourtConnect; Court of Chancery not included) and Arizona (apps.azcourts.gov/publicaccess, which has an official channel to request high-volume access) are the candidates; PartnerFacts will request written permission before any automated search. Federal courts are searched through CourtListener / RECAP.

4. Differences between public sources

Comparisons cover issuers and sponsor groups — see the issuer pages under Deals

7 differences found between the filings for Oded Orgil (compared 11 filings on Oct 24, 2026)

Note · Aug 25, 2023 – Oct 2, 2023

Form D filed 38 days after the first sale — NurExone Biologic Inc.

The filing says the first sale was Aug 25, 2023. The Form D was filed Oct 2, 2023 — 38 days later. The rule: a Form D is generally due within 15 days after the first sale, so this one is 23 days past that.

What this means A late notice is common and carries no penalty by itself. It is worth asking the sponsor why the paperwork lagged.

Sources
Note · Aug 20, 2025 – Aug 27, 2025

No amendment in the last 12 months on an offering that may still be open — NurExone Biologic Inc. (latest filing Aug 27, 2025)

The latest filing for this offering is dated Aug 27, 2025 (first sale Aug 20, 2025). It reports $147,846 sold of $243,231 offered. No later amendment is in our index as of Oct 24, 2026.

What this means SEC rules expect a yearly amendment while an offering is still going. The raise may simply have ended — a Form D does not say when it closed. Ask the sponsor whether the offering closed, when, and at what amount.

Sources
Note · Apr 9, 2025 – Apr 22, 2025

No amendment in the last 12 months on an offering that may still be open — NurExone Biologic Inc. (latest filing Apr 22, 2025)

The latest filing for this offering is dated Apr 22, 2025 (first sale Apr 9, 2025). It reports $1,627,604 sold of $3,756,009 offered. No later amendment is in our index as of Oct 24, 2026.

What this means SEC rules expect a yearly amendment while an offering is still going. The raise may simply have ended — a Form D does not say when it closed. Ask the sponsor whether the offering closed, when, and at what amount.

Sources
Note · Jan 4, 2024 – Jan 9, 2024

No amendment in the last 12 months on an offering that may still be open — NurExone Biologic Inc. (latest filing Jan 9, 2024)

The latest filing for this offering is dated Jan 9, 2024 (first sale Jan 4, 2024). It reports $1,111,542 sold of $2,500,969 offered. No later amendment is in our index as of Oct 24, 2026.

What this means SEC rules expect a yearly amendment while an offering is still going. The raise may simply have ended — a Form D does not say when it closed. Ask the sponsor whether the offering closed, when, and at what amount.

Sources
Note · Mar 25, 2024 – Jan 22, 2025

Address moved from Bnei-Brak, Israel (as filed: L3) to Technion City, Haifa, Israel (as filed: L3) — NurExone Biologic Inc.

The people listed on the Mar 25, 2024 filing give Bnei-Brak, Israel (as filed: L3); on the Jan 22, 2025 filing they give Technion City, Haifa, Israel (as filed: L3).

What this means Businesses move; this just shows the two places and dates. If you were told one city and the forms say another, ask which is current.

Sources
Note · Oct 2, 2023 – Aug 21, 2026

Oded Orgil is listed with 2 different address states: L3, A0

Israel (as filed: L3) on 10 filings (Oct 2, 2023 to Aug 21, 2026); Alberta, Canada (as filed: A0) on 1 filing (Jan 22, 2025).

What this means The address on a Form D is usually the company's, not the person's home, so this often just reflects different companies. It can also mean a move. Nothing wrong by itself.

Sources
Note · Oct 2, 2023

Formed in 2025 per the latest filing, but activity is dated 2023 — NurExone Biologic Inc.

The issuer's latest filing says it was formed in 2025. The Oct 2, 2023 filing says the first sale was Aug 25, 2023 — before that year.

What this means A company cannot sell before it exists, so one of the two dates is likely a typo on the form. Ask the sponsor for the formation document.

Sources
What is compared

What is compared: every Form D and D/A we hold for this subject, side by side — filing dates vs. first-sale dates (the 15-day rule), amendment timing on open offerings (the yearly-amendment expectation), amounts sold, investor counts, offering amounts and minimums across amendments, industry and size bands, addresses, how each person's name and role is written, paid sellers' CRD numbers, and (for groups) where the member companies were formed and sit. Everything is as filed by the issuer; the SEC does not check it. Differences are common and usually have ordinary explanations — we show both values, the dates, and the source so you can ask. As of Oct 24, 2026.

5. Money to insiders

None reported on 11 offerings — no sales commissions, finder's fees or proceeds to insiders

Per-offering detail
Offering (latest filing)Sales commissionsFinder's feesTo insidersPaid to sell itSource
Aug 21, 2026 D
NurExone Biologic Inc.
File 021-594958
$0$0$0None listed on this filingEDGAR ↗
Jul 2, 2026 D
NurExone Biologic Inc.
File 021-589452
$0$0$0None listed on this filingEDGAR ↗
Mar 18, 2026 D
NurExone Biologic Inc.
File 021-576876
$0$0$0None listed on this filingEDGAR ↗
Aug 27, 2025 D
NurExone Biologic Inc.
File 021-555963
$0$0$0None listed on this filingEDGAR ↗
Apr 22, 2025 D
NurExone Biologic Inc.
File 021-544231
$0$0$0None listed on this filingEDGAR ↗
Jan 22, 2025 D
NurExone Biologic Inc.
File 021-535978
$0$0$0None listed on this filingEDGAR ↗
Mar 25, 2024 D
NurExone Biologic Inc.
File 021-508524
$0$0$0None listed on this filingEDGAR ↗
Mar 25, 2024 D
NurExone Biologic Inc.
File 021-508530
$0$0$0None listed on this filingEDGAR ↗
Mar 25, 2024 D
NurExone Biologic Inc.
File 021-508546
$0$0$0None listed on this filingEDGAR ↗
Jan 9, 2024 D
NurExone Biologic Inc.
File 021-501903
$0$0$0None listed on this filingEDGAR ↗
Oct 2, 2023 D
NurExone Biologic Inc.
File 021-493526
$0$0$0None listed on this filingEDGAR ↗

Counts come from Form D Items 12–15 on the filings in our index (latest filing per offering; one offering = one SEC file number; an amendment updates its offering rather than adding one). "To insiders" = gross proceeds used for payments to executive officers, directors or promoters. "—" = not reported on that filing. Amounts marked (est.) were reported as estimates. "Paid to sell it" = sales compensation recipients named on that filing (Item 12), each linked to FINRA BrokerCheck when a CRD number is reported.

Counted across every filing this person is listed on (latest filing per offering, per issuer).

Deals 1

Every issuer that named Oded Orgil on a Form D, newest first. A Form D is the notice a company files after it starts selling a private investment.

Biotechnology

NurExone Biologic Inc.

Technion City, Haifa, Israel (as filed: L3) · Oct 2, 2023 → Aug 21, 2026 · 11 filings
  • Aug 21, 2026 · D · $450,456 sold of $450,456 · 2 investors · min. No minimum reported · role: Director EDGAR ↗
  • Jul 2, 2026 · D · $441,779 sold of $441,779 · 2 investors · min. No minimum reported · role: Director EDGAR ↗
  • Mar 18, 2026 · D · $279,910 sold of $279,910 · 4 investors · min. No minimum reported · role: Director EDGAR ↗
  • Aug 27, 2025 · D · $147,846 sold of $243,231 · 1 investors · min. No minimum reported · role: Director EDGAR ↗
  • Apr 22, 2025 · D · $1,627,604 sold of $3,756,009 · 1 investors · min. No minimum reported · role: Director EDGAR ↗
  • Jan 22, 2025 · D · $434,512 sold of $434,512 · 6 investors · min. No minimum reported · role: Director EDGAR ↗
  • Mar 25, 2024 · D · $42,634 sold of $42,634 · 1 investors · min. No minimum reported · role: Director EDGAR ↗
  • Mar 25, 2024 · D · $1,018,224 sold of $1,018,224 · 4 investors · min. No minimum reported · role: Director EDGAR ↗
  • Mar 25, 2024 · D · $430,296 sold of $430,296 · 5 investors · min. No minimum reported · role: Director EDGAR ↗
  • Jan 9, 2024 · D · $1,111,542 sold of $2,500,969 · 3 investors · min. No minimum reported · role: Director EDGAR ↗
  • Oct 2, 2023 · D · $742,166 sold of $742,166 · 6 investors · min. No minimum reported · role: Director EDGAR ↗

Raised $1.63M from 6 investors (100% of the $450K target) as of the latest filing. Oded is listed as director on 11 filings for this deal.

Sources

Every row is a Form D or D/A on which the issuer listed this name as a related person. Amount sold and investors are the maximum reported on any filing for this issuer. "Similar" = offerings in the same industry claiming the same exemption, filed in the last 5 years: Biotechnology / 506(b) (3,253 filings); ranges are the middle half (25th–75th percentile). Computed by PartnerFacts from SEC EDGAR Form D data as of Oct 23, 2026, 5:45 PM ET. Rows without a range: fewer than 30 comparable filings, or not a Rule 506 offering. No ranking or score.

People around Oded 7

Officers, directors, promoters and management entities named on the same filings, as of Oct 23, 2026, 5:45 PM ET.

YD
No photo found yet (own website and image search run after this page is viewed)
Person

Yoram Drucker

Director, Executive Officer · 11 shared filings (1 issuer) · also on 4 other issuers

Yoram Drucker is on 5 issuers in total — a repeat sponsor. Their page lists every one.

LS
No photo found yet (own website and image search run after this page is viewed)
Person

Lior Shaltiel

Director, Executive Officer · 11 shared filings (1 issuer)

Listed on the same filings as Oded Orgil. Their page shows their other deals.

EO
No photo found yet (own website and image search run after this page is viewed)
Person

Eran Ovadya

Executive Officer · 11 shared filings (1 issuer)

Listed on the same filings as Oded Orgil. Their page shows their other deals.

JR
No photo found yet (own website and image search run after this page is viewed)
Person

James Richardson

Director · 10 shared filings (1 issuer) · also on 1 other issuer

Listed on the same filings as Oded Orgil. Their page shows their other deals.

GR
No photo found yet (own website and image search run after this page is viewed)
Person

Gadi Riesenfeld

Director · 4 shared filings (1 issuer)

Listed on the same filings as Oded Orgil. Their page shows their other deals.

EG
No photo found yet (own website and image search run after this page is viewed)
Person

Eyal Gabbai

Director · 3 shared filings (1 issuer)

Listed on the same filings as Oded Orgil. Their page shows their other deals.

DS
No photo found yet (own website and image search run after this page is viewed)
Person

David Stolick

Director · 1 shared filing (1 issuer)

Listed on the same filings as Oded Orgil. Their page shows their other deals.

Registrations and other filings

Adviser registration (Form ADV)

None of the 1 issuer this person is listed on appears in Form ADV (searched 24,962 advisers as of Oct 2, 2026). A person is never an adviser firm; Form ADV is checked for the issuers and the management companies they are listed with.

Other offering types (Regulation A and Regulation Crowdfunding)

Searched SEC Regulation A Data Sets (Forms 1-A, 1-K, 1-Z; 2015 Q2 → 2026 Q3); SEC Crowdfunding Offerings Data Sets (Form C family; 2016 Q2 → 2026 Q3); EDGAR form index for 2026 Q3 → 2026 Q4 (51,358 records as of Oct 23, 2026, 8:41 PM ET) — nothing matched this name.

Property records none — individuals are not matched

Property records are matched to companies only, never to individuals, so none are matched to Oded Orgil by design. Searched property records in Hillsborough County FL (Clerk recorded-document index Oct 14, 2026 to Oct 15, 2026 + FL DOR 2026 ownership roll), Miami-Dade County FL (FL DOR 2026 ownership roll), Harris County TX (HCAD 2026 ownership roll), Dallas County TX (DCAD 2026 ownership roll), New York City ACRIS documents and PLUTO ownership rows already retrieved for other issuers, Cook County IL sale and ownership rows already retrieved for other issuers (814,874 records as of Oct 23, 2026, 8:59 PM ET) for the 1 issuer this person is listed on — nothing matched.

Public profiles and social

Websites and social links of the issuers Oded Orgil is listed on: none on file. No website or social profile named in NurExone Biologic Inc.'s SEC filings (Form C, Reg A, Form ADV; checked Oct 24, 2026). Web search for this name: #12,629 of 374,652 in line (14 issuers searched so far). One-tap searches: Look further ↓

Look further

One-tap searches on sites we do not index ourselves, with the name pre-filled (Technion City, Haifa, L3). Each opens in a new tab; what you find there is not verified by PartnerFacts.

Business registries

Change history

No corrections have been requested for this page.

Every fact links to its public-record source. Plain-English notes next to a fact are our reading of that fact, not a rating. Request a correction · Facts policy

Request a correction

Free. Logged with status: received → under review → fixed / confirmed with source.

Add a response

If this is you or your firm, add a sourced explanation next to any fact. Reviewed before publishing.

Monitor this person

Members get an email when Oded Orgil appears on a new Form D, or when a court case or SEC action is matched to them. See plans →